PDS Biotechnology’s (PDSB) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note released on Monday morning,Benzinga reports. The brokerage currently has a $21.00 price objective on the stock. PDSB has been the subject of several other reports. B. Riley reduced their target price on PDS Biotechnology from $9.00 […]
HC Wainwright restated their buy rating on shares of PDS Biotechnology (NASDAQ:PDSB – Free Report) in a research note released on Monday morning,Benzinga reports. The brokerage currently has a $21.00 price objective on the stock. PDSB has been the subject of several other reports. B. Riley reduced their target price on PDS Biotechnology from $9.00 […]
